Developed with Swiss innovation, the new RHA Collection of fillers is designed to be more like the natural hyaluronic acid in your skin.
Designed for Facial Dynamics
Beautiful at rest.
Flawless in motion.
RHA—Resilient Hyaluronic Acid—is made to more closely mimic natural HA and move with the dynamic demands of your face.
The RHA Collection of fillers are the first and only FDA-approved HA fillers for dynamic wrinkles and folds.
Dynamic wrinkles and folds appear in areas of the face which move repetitively. RHA is designed to be resilient enough to adapt to your facial movement, which may provide a more natural look at rest and in motion.
Clean Beauty, Expertly Created
Your skin contains hyaluronic acid (HA), which provides moisture, volume and structure. The RHA Collection is intentionally made to be more like the natural HA in your skin.
RHA uses a gentle manufacturing process with few chemical modifications.
This helps preserve the natural structure of the HA, allowing it to mimic the natural HA found in your skin.
Swiss Designer Filler
The RHA Collection developed by TEOXANE Laboratories in Geneva, Switzerland, represents the latest advancement in HA filler technology.
TEOXANE’s founder, Valérie Taupin, was one of the original co-creators of Juvéderm two decades ago and is one of the world’s leading experts in beauty and aesthetics.
Madame Taupin recognized that traditional fillers did not meet all the demands of facial movement for a natural looking outcome. To create RHA, she tasked her R&D team to develop a filler that was made differently – a resilient filler that moves seamlessly with the dynamic areas of the face.
Natural looking results for dynamic areas of the face.
The RHA Collection is designed to be long lasting—up to 15 months.*
*Clinical effectiveness and safety was demonstrated in two 15-month clinical studies for the treatment of moderate to severe nasolabial folds. The primary endpoint of change in wrinkle severity at 6 months was met and RHA maintained non-inferiority to the respective comparator throughout the study up to 15 months.